The Institute for Cancer Research (ICR) was and is a hotbed for basic and translational discovery. Initially a standalone institute, the ICR is currently the main science engine for the Fox Chase Cancer Center.
In the trenches on the medicine wards and smoking cessation clinics at Parkland Hospital and UT Southwestern Simmons Cancer Center, I see firsthand the increased prevalence of smoking in the Black population, their frequent use of menthol, and the ravaging toll it takes on their health.
It’s no secret that cancer center marketing and communications has changed drastically over the past 20 years. With the evolution of consumerism and managed care, the immense growth in scope and scale of cancer center activities and the ever-growing dominance of digital marketing and communications is increasingly integral to the work of cancer center executives as they advance patient care and research and boost the bottom lines of even health systems and parent institutions. The NCI Public Affairs & Marketing Network (PAMN) has been a key player and partner through it all.
The rapid acceleration of drug development has exponentially increased the therapeutic options available to patients with cancer.
With the Russian invasion stalled and with a forceful counter-attack by Ukrainian armed forces, many observers caution that the Kremlin might be considering a show of force much as the U.S. did in the atomic bombings of Hiroshima and Nagasaki (The Cancer Letter, Feb. 25, March 4, March 11, 2022).
As a global cancer society, ASCO represents oncology professionals in Ukraine and its neighboring countries, including Poland, Romania, Moldova, Slovakia, and Hungary.
As we enter week three of the Russian invasion of Ukraine, events continue to spiral out of control.
On Feb. 23, two exciting cancer initiatives converged in San Antonio, Texas: the Biden Administration’s Cancer Moonshot, and the third Advancing the Science of Cancer in Latinos biennial conference.
Ukraine has a special place in my heart, in my career, and in my life. A Ukrainian breast cancer project first introduced me to the field of global oncology, along with experience of seeing first-hand the challenges (and rewards) of providing cancer care and conducting cancer research in a setting of constrained resources. From my […]
In last week’s issue of The Cancer Letter, I discussed potential nuclear dangers resulting from Russia’s invasion of Ukraine (The Cancer Letter, Feb. 25, 2022). Unfortunately, several events I predicted might happen have occurred.
